Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
203M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
+15.9M
-
Total reported value, excl. options
-
$696M
-
Value change
-
+$388M
-
Number of buys
-
75
-
Number of sells
-
-11
-
Price
-
$24.35
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2020
87 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 203M outstanding shares and own 14.09% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.72M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.37M shares), BlackRock Inc. (2.3M shares), Polar Capital LLP (1.77M shares), VANGUARD GROUP INC (1.69M shares), PERCEPTIVE ADVISORS LLC (1.1M shares), PICTET ASSET MANAGEMENT LTD (1.09M shares), BVF INC/IL (1.09M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (871K shares), and Camber Capital Management LP (800K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.